Adicet Bio (ACET) Competitor Comparison
We are evaluating the key criteria listed to compare Adicet Bio (ACET) against its competitors in the Biotechnology industry.
Market Capitalization
227 / 368Gross Profits
82 / 278Total Revenue
298 / 300EBITDA
230 / 337Free Cashflow
248 / 352Quick Ratio
89 / 357Earnings per Share
234 / 359Dividend yield
0 / 6Total Cash
168 / 358Performance 3 years
292 / 368Performance 5 years
350 / 368Performance 10 years
332 / 368Linearity 3 years
128 / 368Linearity 5 years
107 / 368Linearity 10 years
273 / 368Total Rank
182 / 368Dividend Rank
14 / 368Valuation Rank
311 / 368Piotroski Rank
57 / 368Muliplier Rank
106 / 368Market Capitalization - ACET ranking 227 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.